Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : TAK crawled date : 2022 - 02 - 18 save search
Alofisel®▼ (darvadstrocel) Shows Clinical Remission Rate at Six-Months in the Real-World INSPIRE Study Interim Analysis Consistent with the Pivotal Clinical ADMIRE-CD Study1,2
Published: 2022-02-18 (Crawled : 12:30) - biospace.com/
TAK | $13.15 -0.61% 0.0% 1.6M
|
Health Technology
|
| O: 0.13%
H: 0.52%
C: 0.46%
alofisel cel
Exelixis Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
Published: 2022-02-17 (Crawled : 00:00) - biospace.com/
TAK | $13.15 -0.61% 0.0% 1.6M
|
Health Technology
|
| O: 0.07%
H: 0.36%
C: -0.07%
BMY | $47.84 -0.87% -0.02% 12M
|
Health Technology
|
| O: -0.15%
H: 0.41%
C: -0.16%
MSFT F | $411.75 -0.68% -0.69% 16M
|
Technology Services
|
| O: -1.05%
H: 0.15%
C: -1.9%
EXEL | $22.875 0.24% 0.24% 2.8M
|
Health Technology
|
| O: -0.42%
H: 0.89%
C: -3.47%
financial results ces results
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.